Shanghai Pharmaceuticals Holding Co., Ltd
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SHPMF research report →
About the company
Shanghai Pharmaceuticals Holding Co. , Ltd. functions as an investment holding company deeply involved in various facets of China's pharmaceutical and healthcare sectors.
- CEO
- Qiuhua Yang
- IPO
- 2013
- Employees
- 49,402
- HQ
- Shanghai, CN
Price Chart
- Market Cap
- $8.46B
- P/E
- 10.27
- P/S
- 0.21
- P/B
- 0.77
- EV/EBITDA
- 8.11
- Div Yield
- 2.54%
- Gross Margin
- 10.83%
- Op Margin
- 3.53%
- Net Margin
- 2.02%
- ROE
- 7.64%
- ROIC
- 4.62%
- Revenue
- $283.58B · 3.03%
- Net Income
- $5.72B · 25.74%
- EPS
- $1.54 · 25.20%
- Op Income
- $9.94B
- FCF YoY
- 11.73%
- 52W High
- $15.70
- 52W Low
- $1.46
- 50D MA
- $1.49
- 200D MA
- $1.53
- Beta
- 0.21
- Avg Volume
- 1
Get TickerSpark's AI analysis on SHPMF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our SHPMF coverage
Recent articles, reports, and earnings notes.
No research on SHPMF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SHPMF report →Similar companies
Peers in the same neighborhood.